Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$876K Sell
6,815
-224
-3% -$26.2K 0.61% 49
2026
Q1
$847K Sell
7,039
-97
-1% -$11.2K 0.63% 53
2025
Q4
$751K Buy
7,136
+43
+0.6% +$4.04K 0.58% 56
2025
Q3
$595K Buy
+7,093
New +$584K 0.47% 62

Other funds holding MRK

LifePlan Financial's MRK Position: Q2 2026 in Review

LifePlan Financial reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $26.2K and leaving 6,815 shares worth $876K. The position accounts for 0.61% of the portfolio, ranked #49.

LifePlan Financial first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • LifePlan Financial held 6,815 shares of Merck worth $876K as of Q2 2026.
  • LifePlan Financial sold 224 Merck shares in Q2 2026, an estimated $26.2K.
  • Merck made up 0.61% of LifePlan Financial's portfolio in Q2 2026, its #49 holding.
  • LifePlan Financial first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.